Matthew J. Wong - Concepedia

Author

Matthew J. Wong

Oregon Health & Science University

Also Known As

M J Wong, Matthew J. Wong, Matthew Wong

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

Oregon Health & Science University Portland VA Medical Center Howard Hughes Medical Institute

About

Matthew J. Wong is an author at Oregon Health & Science University specializing in medicine, cell biology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	584
2	Engineering	1	1	25
3	Health Sciences	1	1	17
4	Public Health	1	1	14
5	Blood Transplantation	1	1	12

Matthew J. Wong

Publications

Citations

H-Index

Page 1

	Year	Citations
Ponatinib (AP24534), a Multitargeted Pan-FGFR Inhibitor with Activity in Multiple FGFR-Amplified or Mutated Cancer Models Joseph M. Gozgit, Matthew J. Wong, Lauren Moran, Molecular Cancer Therapeutics	2012	317
Activating alleles of JAK3 in acute megakaryoblastic leukemia Denise K. Walters, Thomas Mercher, Ting-Lei Gu, Cancer Cell Hematological MalignancyMixed-phenotype Acute LeukemiaGeneticsAcute Megakaryoblastic LeukemiaHematology	2006	313
Potent Activity of Ponatinib (AP24534) in Models of FLT3-Driven Acute Myeloid Leukemia and Other Hematologic Malignancies Joseph M. Gozgit, Matthew J. Wong, Scott Wardwell, Molecular Cancer Therapeutics Hematological MalignancyVitro Inhibitory ActivityMutant Bcr-ablMedicineAcute Myeloid Leukemia	2011	151
SGX393 inhibits the CML mutant Bcr-Abl <sup>T315I</sup> and preempts <i>in vitro</i> resistance when combined with nilotinib or dasatinib Thomas O’Hare, Christopher A. Eide, Jeffrey Tyner, Proceedings of the National Academy of Sciences	2008	79
Mutations of the BCR-ABL-kinase domain occur in a minority of patients with stable complete cytogenetic response to imatinib Daniel W. Sherbenou, Matthew J. Wong, Adil Humayun, Leukemia Hematological MalignancyMedicineGeneticsCancer GeneticsMolecular Diagnostics	2007	77
Design of an Eta-Phase Precipitation-Hardenable Nickel-Based Alloy with the Potential for Improved Creep Strength Above 1023 K (750 °C) Matthew J. Wong, Paul G. Sanders, John Shingledecker, Metallurgical and Materials Transactions A Materials ScienceMaterials EngineeringEngineeringImproved Creep StrengthMechanical Engineering	2015	25
Plinabulin plus docetaxel versus docetaxel in patients with non-small-cell lung cancer after disease progression on platinum-based regimen (DUBLIN-3): a phase 3, international, multicentre, single-blind, parallel group, randomised controlled trial Baohui Han, Trevor Feinstein, Yuankai Shi, The Lancet Respiratory Medicine OncologyAdvanced Lung DiseaseDocetaxel Versus DocetaxelClinical TrialsPathology	2024	17
Pulmonary and neuromuscular complications of mixed connective tissue disease: a report and review of the literature. J B Martyn, Matthew J. Wong, Shao Hui Huang PubMed Heart FailureVasculitisPathologyPulmonary HypertensionSurgery	1988	14
Good Clinical Response in a Rare Aggressive Hematopoietic Neoplasm: Plasmacytoid Dendritic Cell Leukemia with No Cutaneous Lesions Responding to 4 Donor Lymphocyte Infusions Following Transplant Amir Steinberg, Rina Kansal, Matthew J. Wong, Case Reports in Transplantation Cell TherapyRare MalignancyImmunologyDermatologyImmunotherapy	2011	12
Inhibition of T315I Bcr-Abl and Other Imatinib-Resistant Bcr-Abl Mutants by the Selective Abl Kinase Inhibitor SGX70393. Thomas O’Hare, Christopher A. Eide, Jeffrey Tyner, Blood	2006	11

Page 1